X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (842) 842
Publication (102) 102
Patent (24) 24
Book Chapter (4) 4
Book Review (4) 4
Book / eBook (3) 3
Conference Proceeding (3) 3
Web Resource (3) 3
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (394) 394
oncology (348) 348
index medicus (286) 286
female (238) 238
male (204) 204
middle aged (198) 198
cancer (191) 191
adult (188) 188
aged (179) 179
sarcoma (147) 147
chemotherapy (131) 131
treatment outcome (109) 109
tumors (109) 109
prognosis (106) 106
aged, 80 and over (94) 94
life sciences (94) 94
imatinib mesylate (90) 90
antineoplastic agents - therapeutic use (83) 83
disease-free survival (69) 69
hematology, oncology and palliative medicine (69) 69
adolescent (68) 68
young adult (68) 68
metastasis (67) 67
gastrointestinal stromal tumors - drug therapy (66) 66
imatinib (65) 65
survival (65) 65
sarcoma - drug therapy (62) 62
care and treatment (61) 61
france (57) 57
patients (56) 56
[ sdv.can ] life sciences [q-bio]/cancer (54) 54
benzamides (54) 54
gastrointestinal stromal tumors (53) 53
retrospective studies (53) 53
antineoplastic combined chemotherapy protocols - therapeutic use (51) 51
research (51) 51
sarcoma - pathology (51) 51
surgery (51) 51
analysis (49) 49
pyrimidines - therapeutic use (49) 49
gist (48) 48
therapy (48) 48
diagnosis (47) 47
trial (45) 45
antineoplastic agents - adverse effects (44) 44
clinical trials (44) 44
neoplasm staging (44) 44
gastrointestinal stromal tumors - pathology (43) 43
piperazines - therapeutic use (42) 42
phase-ii (40) 40
mutation (39) 39
expression (38) 38
disease progression (37) 37
kaplan-meier estimate (36) 36
antineoplastic agents (35) 35
follow-up studies (35) 35
survival analysis (35) 35
c-kit (34) 34
combined modality therapy (34) 34
efficacy (34) 34
gastrointestinal stromal tumors - genetics (34) 34
mesh : humans (33) 33
mesylate (33) 33
neoplasm metastasis (33) 33
breast cancer (32) 32
cancer therapies (32) 32
drug therapy (32) 32
management (32) 32
mutations (32) 32
prognostic-factors (32) 32
risk factors (32) 32
child (31) 31
doxorubicin (31) 31
kit (31) 31
proto-oncogene proteins c-kit - genetics (31) 31
sarcoma - mortality (31) 31
antineoplastic agents - administration & dosage (30) 30
soft-tissue sarcoma (30) 30
time factors (30) 30
sarcoma - therapy (29) 29
soft-tissue sarcomas (29) 29
[sdv.can]life sciences [q-bio]/cancer (28) 28
cancer research (28) 28
research article (28) 28
medicine (27) 27
neoplasms (27) 27
trabectedin (27) 27
multivariate analysis (26) 26
patient outcomes (26) 26
soft tissue sarcoma (26) 26
survival rate (26) 26
drug administration schedule (25) 25
france - epidemiology (25) 25
metastases (25) 25
safety (25) 25
animals (24) 24
gastrointestinal stromal tumor (24) 24
ifosfamide (24) 24
medical prognosis (24) 24
prospective studies (24) 24
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_6
Abstract Soft tissue and visceral sarcomas (STS) constitute a heterogeneous group of rare connective tissue cancers, with very variable clinical presentations,... 
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 07/2019, Volume 31, Issue 4, pp. 302 - 303
Journal Article
Future Oncology, ISSN 1479-6694, 05/2018, Volume 14, Issue 10s, pp. 1 - 2
Journal Article
Future oncology (London, England), 09/2019
Soft tissue sarcomas (STS) are heterogenous cancers encompassing more than 100 histological and molecular subtypes. Their extreme rarity underscores the need... 
Journal Article
Future oncology (London, England), 05/2018, Volume 14, Issue 10s, p. 3
Surgery (+ radiation therapy in selected cases) is standard treatment for adult-type localized soft tissue sarcoma (STS). Accumulating randomized clinical... 
Journal Article
Future oncology (London, England), 05/2018, Volume 14, Issue 10s, p. 1
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2010, Volume 37, Issue 5, pp. 373 - 384
Summary The introduction of molecularly targeted therapies has ushered in a considerable transformation in the management of gastrointestinal stromal tumors... 
Hematology, Oncology and Palliative Medicine | Imatinib | Sunitinib | GIST | Tyrosine kinase inhibitor | Gastrointestinal stromal tumor | PDGFRA MUTATIONS | BCR-ABL | RESIDUAL DISEASE | OF-FUNCTION MUTATIONS | PHASE-II TRIAL | SELECTIVE INHIBITOR | ONCOLOGY | KIT MUTATIONS | DOSE IMATINIB | GASTROINTESTINAL STROMAL TUMORS | IMATINIB MESYLATE | Piperazines - administration & dosage | Protein-Tyrosine Kinases - therapeutic use | Prognosis | Humans | Male | Indoles - administration & dosage | Drug Delivery Systems | Enzyme Inhibitors - administration & dosage | Angiogenesis Inhibitors - administration & dosage | Pyrroles - administration & dosage | Pyrroles - adverse effects | Adult | Female | Gastrointestinal Stromal Tumors - mortality | Angiogenesis Inhibitors - adverse effects | Gastrointestinal Stromal Tumors - genetics | Enzyme Inhibitors - adverse effects | Gastrointestinal Stromal Tumors - surgery | Pyrimidines - administration & dosage | Imatinib Mesylate | Piperazines - adverse effects | Disease-Free Survival | Pilot Projects | Indoles - adverse effects | Gastrointestinal Stromal Tumors - drug therapy | Pyrimidines - adverse effects | Survival Analysis | Benzamides | Neoplasm Staging | Clinical Trials, Phase I as Topic | Clinical Trials, Phase II as Topic | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Phenols | Care and treatment | Tumors | Enzyme Inhibitors | Piperazines | Pyrroles | Angiogenesis Inhibitors | Life Sciences | Pyrimidines | Indoles | Protein-Tyrosine Kinases | Gastrointestinal Stromal Tumors | Cancer
Journal Article
Future oncology (London, England), 06/2017, Volume 13, Issue 13s, p. 3
Journal Article
Future oncology (London, England), 01/2017, Volume 13, Issue 1s, p. 1
Journal Article
The Lancet, ISSN 0140-6736, 2013, Volume 381, Issue 9863, pp. 295 - 302
Background Until now, only imatinib and sunitinib have proven clinical benefi t in patients with gastrointestinal stromal tumours (GIST), but almost all... 
Journal Article
Future Oncology, ISSN 1479-6694, 01/2017, Volume 13, Issue 1s, pp. 1 - 2
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 07/2018, Volume 30, Issue 4, pp. 240 - 242
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 06/2013, Volume 13, Issue sup1, pp. 3 - 9
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 2014, Volume 101, Issue 4, p. 340
Journal Article
Bulletin de l'Académie nationale de médecine, ISSN 0001-4079, 01/2015, Volume 199, Issue 1, pp. 1 - 41
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 70, pp. 83 - 86
Abstract Soft tissue and visceral sarcoma gather a large group of rare to very rare cancers and locally aggressive connective tissue tumours. Novel concepts on... 
Hematology, Oncology and Palliative Medicine | Targeted therapies | Molecular classification | Sarcoma | Surgery | Network | Neoadjuvant | Expert centres | Adjuvant
Journal Article
ISSN 0959-8049, 01/2017, Volume 70, p. 83
Soft tissue and visceral sarcoma gather a large group of rare to very rare cancers and locally aggressive connective tissue tumours. Novel concepts on... 
Connective tissues | Sarcoma | Disease management | Disease control | Molecular chains | Cancer | Tumors
Journal Article
Future Oncology, ISSN 1479-6694, 05/2018, Volume 14, Issue 10s, pp. 3 - 13
Surgery (+ radiation therapy in selected cases) is standard treatment for adult-type localized soft tissue sarcoma (STS). Accumulating randomized clinical... 
management | trabectedin | advanced soft tissue sarcoma | MULTICENTER | DOSE ADJUVANT CHEMOTHERAPY | RANDOMIZED CLINICAL-TRIAL | DOXORUBICIN | PHASE-II | OPEN-LABEL | IFOSFAMIDE | METASTATIC LIPOSARCOMA | ONCOLOGY | LEIOMYOSARCOMA
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 47, pp. ix - ix
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.